Sunshine Biopharma director Dr. Andrew Keller will not seek reelection

Sunshine Biopharma Inc.

Dr. Andrew Keller notified company on Aug 25, 2026 he will not seek reelection.
His term expires at the next annual shareholder meeting; no replacement named.
Board composition will change after his departure.

item 5.02

Sunshine Biopharma Inc. filing history →

Source: SEC EDGAR

accession 0001683168-26-006777

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.